Výsledky vyhledávání - "Kei Furihata"

Akademický článek

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study

Autor: Rino Suzuki, Miharu Suda, Katsuyasu Ishida, Kei Furihata, Aisaku Ota, Kaori Takahashi, Sachiko Sakakibara, Tetsuo Nakayama, Fumihiko Takeshita

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

BackgroundDS-5670 is a messenger ribonucleic acid (mRNA) vaccine platform targeting the receptor-binding domain (RBD) of the spike protein derived from severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Booster vaccination against coronavi

Externí odkaz: https://doaj.org/article/efa4d48f532142d9ae42ac6e676a2296

Zobrazit plný text záznamu

Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data

Autor: Masafumi Sakagami, Koji Oba, Masaru Tsuchikawa, Takaki Miwa, Kei Furihata, Yuji Naito

Publikováno v: Nutrients
Nutrients, Vol 12, Iss 1128, p 1128 (2020)

Zinc intake is recommended for zinc deficiency. In clinical practice, polaprezinc has been used as a zinc replacement therapy for zinc deficiency. However, the efficacy of polaprezinc has not been established. To confirm the efficacy on zinc deficien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140f1e9620b5aef6537fce9b8351db9c
https://pubmed.ncbi.nlm.nih.gov/32316581

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání